Hwang, Yeon Mi
Piekos, Samantha N.
Paquette, Alison G.
Wei, Qi
Price, Nathan D.
Hood, Leroy
Hadlock, Jennifer J.
Funding for this research was provided by:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD091527, HD091527, HD091527)
Article History
Received: 18 May 2024
Accepted: 17 October 2024
First Online: 25 October 2024
Declarations
:
: All procedures were reviewed and approved by the Institutional Review Board at the PSJH through expedited review on 11–04-2020 (study number STUDY2020000196). Consent was waived because disclosure of protected health information for the study involved no more than minimal risk to the privacy of individuals.
: Not applicable.
: Y.H., S.N.P., and A.G.P. declare no conflict of interest. J.J.H. has received research funding (paid to institute) from Pfizer, Novartis, Janssen, Gilead and Bristol Myers Squibb. Q.W. has been funded in part by Pfizer, Novartis, and Janssen (paid to the institute). L.H. and N.D.P. are scientific advisors for Sera Prognostics, a pregnancy diagnostics company, and N.D.P. holds stock options. Sera Prognostics is not associated with this study or any of the findings.